Compare Fifth Third Bancorp Common Stock (FITB) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fifth Third Bancorp Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Fifth Third Bancorp Common Stock trades at $50.53 (market cap $45.98B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Fifth Third Bancorp Common Stock is far larger — about 3.7× Halozyme Therapeutics Inc. Common Stock's market cap, and Fifth Third Bancorp Common Stock pays a 3.31% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fifth Third Bancorp Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FITB | HALO | |
|---|---|---|
Market Cap | $45.98B | $12.58B |
Volume | 10,522,320 | 2,179,278 |
Sector | Financials | Health |
52-Week High | $59.37 | $115.22 |
52-Week Low | $40.36 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $63.85B | $14.49B |
Dividend Yield | 3.31% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fifth Third Bancorp Common Stock
Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.
Read more on FITB →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
